{"id":"W4410808236","doi":"10.1200/jco.2025.43.16_suppl.e17127","title":"Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide (enza) plus leuprolide (combo): EMBARK post hoc analysis.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Post-hoc analysis; Oncology; Internal medicine; Cancer; Prostate; Gynecology; Urology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003152145,0.0008155361,0.001888127,0.0004098303,0.0002266772,0.0006201238,0.0005425515,0.0007407155,0.004109713],"category_scores_gemma":[0.002430783,0.0002359976,0.003931629,0.0004178613,0.0003949026,0.0007791637,0.0005159444,0.001649667,0.0003300287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005106695,"about_ca_system_score_gemma":0.000902227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004758341,"about_ca_topic_score_gemma":0.001405083,"domain_scores_codex":[0.9987577,0.0006922161,0.00008334743,0.0001748553,0.000121339,0.0001705073],"domain_scores_gemma":[0.9976475,0.001137669,0.0005754702,0.0001459511,0.00009894031,0.00039452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9380244,0.003010629,0.03132473,0.0006124452,0.005193358,0.0001016914,0.00004468826,0.001400527,0.002358538,0.00009499135,0.001455468,0.01637856],"study_design_scores_gemma":[0.185308,0.4905172,0.2945096,0.0001813089,0.0132638,0.0003481468,0.0002127477,0.005931365,0.004348821,0.0007426774,0.004538186,0.00009797369],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949852,0.001250558,0.0003462957,0.0001134212,0.00005733565,0.0005342852,0.001692263,0.00002136543,0.0009993162],"genre_scores_gemma":[0.9929789,0.0004600595,0.0005698329,0.0002585373,0.0001399402,0.001138222,0.003132133,0.00001190876,0.001310515],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004109713,"threshold_uncertainty_score":0.01667035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03541493979559037,"score_gpt":0.4124272667645508,"score_spread":0.3770123269689604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}